Tell your prescriber if you have ever had pancreatitis, diabetic retinopathy, kidney problems, or depression
In a few short years, GLP-1 drugs like Ozempic, Wegovy, Mounjaro and Zepbound have gone from relative obscurity to some of the most sought after medications in the US
The extent to which Ozempic may be covered in Canada depends on your individual situation and health cover providers
Critically, the glucagon component appeared to drive increased energy expenditure and enhanced hepatic lipid oxidation without negating the glucose-lowering benefits conferred by GLP-1 and GIP activity
Research in people without diabetes shows that these medications can lead to steady and meaningful weight loss over time
Its multifaceted nature and relatively low-risk profile make it a compelling candidate for therapeutic intervention across several medical contexts